NCT03847350View on ClinicalTrials.gov

Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential Hypertension

CompletedOBSERVATIONAL

Enrollment

3,250

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

March 23, 2017

Study Completion Date

March 23, 2017

Conditions

Essential Hypertension

Trial Locations (1)

22332

Inha University Hospital, Incheon

All Listed Sponsors

lead

A.Menarini Asia-Pacific Holdings Pte Ltd

INDUSTRY

NCT03847350 - Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential Hypertension | Biotech Hunter | Biotech Hunter